<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A human <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL)-derived cell line, BALM-25, was established from the bone marrow specimen of a 59-year-old male patient with B-cell ALL L3 type (ALL-L3) at diagnosis </plain></SENT>
<SENT sid="1" pm="."><plain>Immunophenotyping indicated mature B-cell characteristics including expression of cell surface and cytoplasmic immunoglobulin (Ig) chains, CD10, CD19, CD20, CD38, CD39, CD40, CD71, NU-B1 and HLA class II </plain></SENT>
<SENT sid="2" pm="."><plain>T-cell and myeloid associated antigens tested were negative except CD5 </plain></SENT>
<SENT sid="3" pm="."><plain>BALM-25 cells have a morphological appearance typical for L3-type lymphoblasts </plain></SENT>
<SENT sid="4" pm="."><plain>Regarding the expression of Ig chains, while the original <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells expressed Ig lambda delta mu and hence a single light (L) chain isotype, the established line revealed double L chain expression both at the cell surface and the cytoplasmic level </plain></SENT>
<SENT sid="5" pm="."><plain>Definitive double L chain expression was confirmed by flow cytometry and Western blot analysis </plain></SENT>
<SENT sid="6" pm="."><plain>Southern blot analysis demonstrated rearrangement of the IgJH, the Ckappa and the Clambda genes </plain></SENT>
<SENT sid="7" pm="."><plain>Cytogenetic analysis of BALM-25 revealed the following numerical and structural abnormalities: 55, X, add(X)(q12), + 2, add(3)(p21), + 5, add(7)(p13), add(11)(p11.2), add(11)(q?23), add(12)(p11.2), add(14)(q22), - 15, + 16, + 16,add(18)(11.2), + 20, + marl, + mar2, + mar3, + mar,inc </plain></SENT>
<SENT sid="8" pm="."><plain>The established cell line, BALM-25, provides an unlimited supply of cell material for analyzing the unique (patho)<z:mp ids='MP_0001532'>physiology</z:mp> of Ig expression in general and for clarifying the pathogenesis of this type of B-cell <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in particular </plain></SENT>
</text></document>